Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza.

Karl G Nicholson1, John M Wood, Maria Zambon

  • 1Infectious Diseases Unit, Leicester Royal Infirmary, Leicester, UK. karlgnicholson@doctors.org.uk

Lancet (London, England)
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the Future of Respiratory Infections: Key Insights From International Congress in Singapore, 17-20 September 2025.

Influenza and other respiratory viruses·2026
Same author

The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019-2023.

Influenza and other respiratory viruses·2026
Same author

Epidemiology of virologically confirmed RSV, influenza and COVID-19 in adults in England, 2023-2024: Primary Care Observational Study of Acute Respiratory Infection (ObservatARI).

The Journal of infection·2026
Same author

Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type.

Wellcome open research·2026
Same author

Enabling genomic surveillance from 30 years of linked English sentinel network data: The Wellcome Quinquagenarian (QQG) Biomedical Resource.

Wellcome open research·2026
Same author

Influenza A(H3N2) Subclade K Virus: Threat and Response.

JAMA·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Influenza control has advanced with new vaccines and antiviral drugs, improving annual outbreak management. Continued research is vital for pandemic preparedness and understanding influenza pathogenicity.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Influenza infections cause significant suffering and economic loss globally.
  • Limited progress in influenza control for decades until recent advancements.
  • Avian influenza strains (H5N1, H9N2, H7N7) pose pandemic threats.

Purpose of the Study:

  • To review recent advances in influenza control strategies.
  • To highlight the importance of vaccination and antiviral therapies.
  • To emphasize the need for ongoing research into pandemic influenza.

Main Methods:

  • Review of evidence on inactivated and live influenza-virus vaccines.
  • Analysis of developments in vaccine technology.
  • Examination of neuraminidase inhibitors and near-patient testing.

Related Experiment Videos

Main Results:

  • Inactivated vaccines offer protection; live vaccines are safe and effective in children.
  • Potent antiviral drugs targeting neuraminidase are now available.
  • Economic modeling supports annual vaccination and antiviral use.
  • Near-patient testing aids diagnosis and surveillance.

Conclusions:

  • Recent advances in vaccines and antivirals enhance influenza management.
  • Emerging avian influenza strains underscore pandemic vulnerability.
  • International research is crucial to understand pathogenicity and prepare for pandemics.
  • Improved surveillance and integrated use of vaccines/antivirals are essential for reducing global influenza impact.